Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study

A recent prospective cohort study using data from the UK Million Women Study with more than 14 years of follow-up reported that asthma requiring treatment was associated with

In order to determine whether HR-HPV E6/E7 mRNA testing more effectively predicts precancerous lesions and invasive cervical cancer than HR-HPV DNA testing, we aimed to compare

Also, previous data on HPV mRNA testing in the triage of ASC-US and LSIL[11,25] show that the HPV mRNA test, due to a high specificity and positive predictive value (PPV), is

Repeat cytology, HPV DNA testing (Roche Cobas 4800), and HPV mRNA testing (NorChip PreTect HPV-Proofer) were used to follow up 575 women aged 25–69 years with ASC- US / LSIL in

The current study demonstrated the high HPV/HIV co-infection of 24.4%, with high hr-HPV prevalence across almost all age groups and more multiple hr- HPV infection in HIV-positive

Participants: After excluding women with a history of abnormal smears and with cervical intraepithelial neoplasia grade 2 (CIN2+) before or until 3 months after screening, 11 220

During the study period, the Norwegian Cervical Cancer Screening Programme (NCCSP) recommended delayed triage of women with minor cervical lesions with repeat cytology and HPV

In the retrospective cohort study (n=655), among 154 women with a history of mood disorder at baseline, 13 (8.5%) developed incident cancer during follow-up, whereas among 501